Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -79.37x as of the fiscal period ended Friday, December 31, 2021.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-79.37x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.95x
median of 420 covered companies
CURRENT VS SECTOR MEDIAN
-1503.47%
vs the sector median at left
4D Molecular Therapeutics, Inc.
Market Cap
$675.93M
Interest Coverage Ratio
-79.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$669.77M
Interest Coverage Ratio
35.83x
TTM Avg
47.17x
3Y Avg
33.36x
5Y Avg
33.36x
Market Cap
$683.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$703.47M
Interest Coverage Ratio
-1286.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$644.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$716.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | $675.93M | -79.37x | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $669.77M | 35.83x | 47.17x | 33.36x | 33.36x |
| Helus Pharma Inc. (HELP)vs › | $683.59M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $661.80M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $693.87M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $703.47M | -1286.22x | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $644.93M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $640.77M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $716.25M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $711.75M | -696.50x | N/A | N/A | N/A |
Interest Coverage
-79.4x
Debt/Equity
0.10
Current Ratio
8.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -79.37x |
